Difficulty: Medium
Average Score: 77%
Practice
A 68-year-old man presents to the emergency department with worsening chest pain. He has a history of congestive heart failure and currently takes digoxin. Physical examination reveals an acutely ill man who is tachypneic. His room air pulse oximetry is 90%. Pulmonary auscultation reveals bilateral wheezing. Neck examination reveals jugular venous distension. Which one of the following is the most appropriate treatment for this patient?
Correct answer
B
Rationale
In this scenario, the most appropriate treatment for the 68-year-old man with worsening chest pain, congestive heart failure, and who is tachypneic with wheezing and jugular venous distension is option B) Dobutamine.
Dobutamine is a sympathomimetic amine that acts primarily on beta-1 adrenergic receptors, leading to increased cardiac contractility and output. Given the patient's presentation with signs of heart failure exacerbation, dobutamine can help improve cardiac function and perfusion, thereby addressing the underlying cause of his symptoms.
Now, let's discuss why the other options are not the most appropriate choices:
A) Albuterol via nebulizer: Albuterol is a beta-2 adrenergic agonist primarily used for bronchodilation in conditions like asthma or COPD. While wheezing is noted in this patient, the primary concern here is addressing his acute heart failure exacerbation, not just his respiratory symptoms.
C) Epinephrine via nebulizer: Epinephrine is a non-selective adrenergic agonist that can increase heart rate and contractility. However, in this case, a more specific agent like dobutamine targeting beta-1 receptors for cardiac support is preferred over the non-selective effects of epinephrine.
D) Norepinephrine: Norepinephrine is a potent vasoconstrictor and increases blood pressure. While it can be used in certain shock states, it is not the first-line choice for a patient with heart failure exacerbation like in this case.
From an educational perspective, understanding the rationale behind choosing the appropriate medication in a clinical scenario is crucial for healthcare providers to deliver safe and effective patient care. This case highlights the importance of considering the underlying pathophysiology and selecting the most targeted therapy to address the primary issue at hand.
Dobutamine is a sympathomimetic amine that acts primarily on beta-1 adrenergic receptors, leading to increased cardiac contractility and output. Given the patient's presentation with signs of heart failure exacerbation, dobutamine can help improve cardiac function and perfusion, thereby addressing the underlying cause of his symptoms.
Now, let's discuss why the other options are not the most appropriate choices:
A) Albuterol via nebulizer: Albuterol is a beta-2 adrenergic agonist primarily used for bronchodilation in conditions like asthma or COPD. While wheezing is noted in this patient, the primary concern here is addressing his acute heart failure exacerbation, not just his respiratory symptoms.
C) Epinephrine via nebulizer: Epinephrine is a non-selective adrenergic agonist that can increase heart rate and contractility. However, in this case, a more specific agent like dobutamine targeting beta-1 receptors for cardiac support is preferred over the non-selective effects of epinephrine.
D) Norepinephrine: Norepinephrine is a potent vasoconstrictor and increases blood pressure. While it can be used in certain shock states, it is not the first-line choice for a patient with heart failure exacerbation like in this case.
From an educational perspective, understanding the rationale behind choosing the appropriate medication in a clinical scenario is crucial for healthcare providers to deliver safe and effective patient care. This case highlights the importance of considering the underlying pathophysiology and selecting the most targeted therapy to address the primary issue at hand.